Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Prophylaxis of postmenopausal osteoporosis
Age: Adult
Dose: Oral – 60 mg
Frequency: once daily
Note: Hepatic impairment: Contraindicated.
Indication: Osteoporosis in postmenopausal women
Age: Adult
Dose: Oral – 60 mg
Frequency: once daily
Note: Hepatic impairment: Contraindicated.

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: NO_HEADER – No approved pediatric dosage available
Note: No approved pediatric dosage available

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment: Severe
Dose: Not mentioned
Note: Contraindicated
Administration
  • Can be taken with or without food
  • Take at same time each day
Side Effect

Drug Interaction

Drug NameRisk Factors
Cholestyramine
Reduces absorption of raloxifene
Warfarin
May reduce prothrombin response and time

Disease Interaction

Disease NameRisk Factors
Deep Vein Thrombosis
Risk of blood clots
Pulmonary Embolism
Risk of lung blood clots

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.